Indeed, although PPARγ was mainly found to inhibit cell proliferation and HCC metastases in vitro and in mice [24–27], recent studies reported pro-tumorigenic effects in HCCs [28–30]. The gene discussed is PPARG; the disease is hepatocellular carcinoma.